70 related articles for article (PubMed ID: 6357591)
21. Guanfacine in essential hypertension: effects during rest and isometric exercise.
Hedner T; Nyberg G; Mellstrand T
Clin Pharmacol Ther; 1984 May; 35(5):604-9. PubMed ID: 6370553
[TBL] [Abstract][Full Text] [Related]
22. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
Gish EC; Miller JL; Honey BL; Johnson PN
Ann Pharmacother; 2010 Feb; 44(2):343-51. PubMed ID: 20040696
[TBL] [Abstract][Full Text] [Related]
23. Early hemodynamic and humoral effects of lofexidine.
Fouad FM; Vidt DG; Williams H; Tarazi RC; Bravo EL
Clin Pharmacol Ther; 1981 Apr; 29(4):498-504. PubMed ID: 7471616
[TBL] [Abstract][Full Text] [Related]
24. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
[TBL] [Abstract][Full Text] [Related]
25. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
[TBL] [Abstract][Full Text] [Related]
26. Animal experiments on the safety pharmacology of lofexidine.
Graf E; Sieck A; Wenzl H; Winkelmann J
Arzneimittelforschung; 1982; 32(8a):931-40. PubMed ID: 6890367
[TBL] [Abstract][Full Text] [Related]
27. Toxicology of the combination lofexidine/hydrochlorothiazide.
Friehe H; Fontaine R; Gibson JP; Larson EJ; Sells DM
Arzneimittelforschung; 1982; 32(8a):966-71. PubMed ID: 6890371
[TBL] [Abstract][Full Text] [Related]
28. Effects of clonidine (Catapresan) on urethral pressure.
Nordling J; Meyhoff HH; Christensen NJ
Invest Urol; 1979 Jan; 16(4):289-91. PubMed ID: 570966
[TBL] [Abstract][Full Text] [Related]
29. Interference of enantiomers of lofexidine with alpha-adrenoceptors.
Wilffert B; Mathy MJ; Batink HD; de Jonge A; Thoolen MJ; Prop G; Graf E; Timmermans PB; van Zwieten PA
Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):18-32. PubMed ID: 2988468
[TBL] [Abstract][Full Text] [Related]
30. Withdrawal phenomena in subjects with essential hypertension on clonidine or tiamenidine.
Hamilton BP; Mersey JH; Hamilton J; Kuzbida G; Pavlis R; Levinson P
Clin Pharmacol Ther; 1984 Nov; 36(5):628-33. PubMed ID: 6488684
[TBL] [Abstract][Full Text] [Related]
31. Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension.
Collart F; Staroukine M; Verniory A
Acta Cardiol; 1985; 40(3):269-76. PubMed ID: 3895792
[TBL] [Abstract][Full Text] [Related]
32. Hydrochlorothiazide-induced sympathetic hyperactivity in hypertensive patients.
Lake CR; Ziegler MG; Coleman MD; Kopin IJ
Clin Pharmacol Ther; 1979 Oct; 26(4):428-32. PubMed ID: 487689
[TBL] [Abstract][Full Text] [Related]
33. Clonidine twice daily in hypertension. Effects of two dosage regimens on blood pressure, side-effects and plasma clonidine concentrations.
Lilja M; Huikuri H; Jounela AJ; Juustila HJ; Paalzow G
Acta Med Scand; 1983; 214(2):111-7. PubMed ID: 6353878
[TBL] [Abstract][Full Text] [Related]
34. Responses to mental stress and physical provocations before and during long term treatment of hypertensive patients with beta-adrenoceptor blockers or hydrochlorothiazide.
Eliasson K; Kahan T; Hylander B; Hjemdahl P
Br J Clin Pharmacol; 1987 Jul; 24(1):1-14. PubMed ID: 2887186
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of long-term treatment of essential hypertension with guanfacine.
Higuchi M; Overlack A; Stumpe KO
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
[TBL] [Abstract][Full Text] [Related]
36. Effect of guanabenz on blood pressure responses to posture and exercise.
Dziedzic SW; Elijovich F; Felton K; Yeager K; Krakoff LR
Clin Pharmacol Ther; 1983 Feb; 33(2):151-5. PubMed ID: 6337003
[TBL] [Abstract][Full Text] [Related]
37. Effect of phenoxybenzamine on cardiovascular and plasma catecholamine responses to clonidine.
Zweifler A; Gross M; Sisson J
Clin Pharmacol Ther; 1983 Feb; 33(2):156-62. PubMed ID: 6822028
[TBL] [Abstract][Full Text] [Related]
38. Platelet function in hypertension and effect of therapy.
Mehta J; Mehta P
Am J Cardiol; 1981 Feb; 47(2):331-4. PubMed ID: 6451166
[TBL] [Abstract][Full Text] [Related]
39. A sliding intravenous dose schedule for clonidine in hypertensive patients.
Velasco M; Gallardo E; Plaja J; Guevara J
Clin Pharmacol Ther; 1976 Jul; 20(1):31-5. PubMed ID: 776490
[TBL] [Abstract][Full Text] [Related]
40. Response of plasma catecholamines and blood pressure to clonidine and to sudden withdrawal of the drug in subjects with essential hypertension.
Planz G; Beckenbauer U; Bundschu HD
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):474-8. PubMed ID: 7141755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
